• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟DNA结合铂(II)-胺配合物中的空间效应。

Modelling steric effects in DNA-binding platinum(II)-am(m)ine complexes.

作者信息

Yuriev E, Orbell J D

机构信息

Department of Environmental Management, Victoria University of Technology, Melbourne, Australia.

出版信息

J Comput Aided Mol Des. 1996 Dec;10(6):589-606. doi: 10.1007/BF00134182.

DOI:10.1007/BF00134182
PMID:9007692
Abstract

A repulsive energy strategy has been employed in an attempt to delineate the steric contribution to the biological profile of a variety of platinum-am(m)ine complexes. Thus, relative steric descriptors have been calculated for the amine ligands themselves by the Ligand Repulsive Energy (LRE) methodology. This has been extended to a Complex Repulsive Energy (CRE) strategy whereby the steric requirements of the approach of a metal complex to a site on a target molecule may be evaluated. Specifically, the monodentate approach of a variety of platinum-am(m)ine complexes to the N7 site of a guanine moiety has been considered. The steric descriptors thus obtained have been used in QSAR analysis, resulting in improved regression equations. Attempts have also been made to relate the above descriptors to various biological indicators for given series of complexes. These investigations suggest an optimum steric requirement for minimum toxicity, which could aid in the rational design of such agents.

摘要

为了描述各种铂胺配合物的空间效应对其生物学特性的贡献,采用了一种斥力能量策略。因此,通过配体斥力能量(LRE)方法计算了胺配体自身的相对空间描述符。这已扩展为一种配合物斥力能量(CRE)策略,据此可以评估金属配合物接近目标分子上某一位置的空间需求。具体而言,考虑了各种铂胺配合物对鸟嘌呤部分N7位点的单齿接近方式。由此获得的空间描述符已用于定量构效关系(QSAR)分析,得到了改进的回归方程。还尝试将上述描述符与给定系列配合物的各种生物学指标联系起来。这些研究表明了最小毒性的最佳空间需求,这有助于此类药物的合理设计。

相似文献

1
Modelling steric effects in DNA-binding platinum(II)-am(m)ine complexes.模拟DNA结合铂(II)-胺配合物中的空间效应。
J Comput Aided Mol Des. 1996 Dec;10(6):589-606. doi: 10.1007/BF00134182.
2
[Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine].[抗肿瘤治疗药物顺铂与含吡嗪的双核二价铂化合物的DNA络合比较]
Mol Biol (Mosk). 2002 Jul-Aug;36(4):745-52.
3
Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex.通过叠氮化铂(IV)配合物的光活化在DNA上形成铂化的GG交联。
J Biol Inorg Chem. 2003 Sep;8(7):741-5. doi: 10.1007/s00775-003-0474-3. Epub 2003 Jul 9.
4
Bis[platinum(II)] and bis[platinum(IV)] complexes with optically active bis(vicinal-1,2-diamines) and their interaction with DNA.具有光学活性双(邻位-1,2-二胺)的双[铂(II)]和双[铂(IV)]配合物及其与DNA的相互作用。
J Inorg Biochem. 1999 Jul 15;75(4):269-79. doi: 10.1016/s0162-0134(99)00099-9.
5
Internalization of Ineffective Platinum Complex in Nanocapsules Renders It Cytotoxic.纳米胶囊中无效铂络合物的内化使其具有细胞毒性。
Chemistry. 2016 Feb 18;22(8):2728-35. doi: 10.1002/chem.201504671. Epub 2016 Jan 20.
6
Design and biological evaluation of new platinum(II) complexes bearing ligands with DNA-targeting ability.具有DNA靶向能力的新型铂(II)配合物的设计与生物学评价
Inorg Chem. 2014 Dec 1;53(23):12627-34. doi: 10.1021/ic502373n. Epub 2014 Nov 17.
7
Research progress in modern structure of platinum complexes.铂配合物现代结构研究进展。
Eur J Med Chem. 2017 Nov 10;140:349-382. doi: 10.1016/j.ejmech.2017.09.034. Epub 2017 Sep 22.
8
DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].新型细胞毒性四功能双核铂配合物反式,反式-[{PtCl2(NH3)}2(哌嗪)]的DNA相互作用
Biochem Pharmacol. 2007 Jun 15;73(12):1887-900. doi: 10.1016/j.bcp.2007.03.003. Epub 2007 Mar 12.
9
Structural studies of interactions between anticancer platinum drugs and DNA.抗癌铂类药物与DNA相互作用的结构研究
Prog Biophys Mol Biol. 1996;66(1):81-111. doi: 10.1016/s0079-6107(96)00017-x.
10
Physicochemical factors for cytotoxic activity in platinum dinuclear complexes with pyrimidine and imide ligands.
Biophys Chem. 1998 Dec 14;75(3):259-70. doi: 10.1016/s0301-4622(98)00213-0.

本文引用的文献

1
Mutagenicity of substituted (o-phenylenediamine)platinum dichloride in the Ames test. A quantitative structure-activity analysis.
J Med Chem. 1980 Apr;23(4):459-61. doi: 10.1021/jm00178a019.
2
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
J Med Chem. 1985 Mar;28(3):333-46. doi: 10.1021/jm00381a013.
3
Toxicities derived from anti-tumor screening data.
Fundam Appl Toxicol. 1986 Feb;6(2):270-7. doi: 10.1016/0272-0590(86)90240-x.
4
MOPAC: a semiempirical molecular orbital program.MOPAC:一个半经验分子轨道程序。
J Comput Aided Mol Des. 1990 Mar;4(1):1-105. doi: 10.1007/BF00128336.
5
Relationship between topological properties and biological activity of platinum (II) complexes.铂(II)配合物的拓扑性质与生物活性之间的关系。
Arch Immunol Ther Exp (Warsz). 1991;39(1-2):75-84.
6
Structure and activity relationships of platinum complexes with anti-tumour activity.
Chem Biol Interact. 1975 Sep;11(3):145-61. doi: 10.1016/0009-2797(75)90095-2.